Journal of Solid Tumors publishes research articles and reviews in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of solid tumors, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. Randomized controlled trials, especially phase III trials and evidence-based meta-analysis or pooled analysis related to specific trials are preferred clinical papers. The primary criterion for publication is interest to a multidisciplinary audience.
The articles of JST are indexed/reviewed in the following databases/resources:
- DOAJ
- EBSCOhost
- Elsevier
- Gale's Academic Databases
- Google Scholar
- HINARI
- Lockss
- PKP Open Archives Harvester
- ProQuest
---------------------------------------------------------------------
Statistics
2013 Q1: Articles Received: 28; Accepted: 14; Rejected: 21; Published: 13; Retracted: 0
---------------------------------------------------------------------
What is e-Version FirstTM
e-Version First is a feature offered through our journal platform. It allows PDF version of manuscripts that have been peer reviewed and accepted, to be hosted online prior to their inclusion in a final printed journal. Readers can freely access or cite the article. We aim to publish accepted manuscripts in e-Version First in two week's time after the final draft completed.
---------------------------------------------------------------------
Paper Selection and Publication Process
a). Upon receipt of paper submission, the Editor sends an E-mail of confirmation to the corresponding author within 1-3 working days. If you fail to receive this confirmation, your submission/e-mail may be missed. Please contact the Editor in time for that.
b). Peer review. We use double-blind system for peer-review; both reviewers and authors' identities remain anonymous. The paper will be peer-reviewed by three experts; two reviewers from outside and one editor from the journal typically involve in reviewing a submission. The review process may take 2-3 weeks.
c). Notification of the result of review by E-mail.
d). The authors revise paper and pay publication fee (200.00 USD).
e). After publication, the corresponding author will receive the copy of printed journal, free of charge.
f). E-journal in PDF is available on the journal’s webpage, free of charge for download.
NOTE:
The publisher and journal have a policy of “Zero Tolerance on the Plagiarism”. We check the plagiarism issue through two methods: reviewer check and plagiarism prevention tool (ithenticate.com).
All submissions will be checked by iThenticate before being sent to reviewers.
Announcements
JST indexed in Elsevier and DOAJ |
|
| Journal of Solid Tumors (JST) has already been indexed in Elsevier and DOAJ. | |
| Posted: 2013-04-06 | |
Acknowledgements to Reviewers 2012 |
|
| We would like to express our gratitude to all ERB members of Journal of Solid Tumors | |
| Posted: 2012-12-27 | More... |
CALL FOR PAPERS |
|
For 2012 issues Publication Frequency of JST: 2012 Bimonthly, published in January, March, May, July, September, November |
|
| Posted: 2011-08-14 | More... |
| More Announcements... |
Vol 3, No 3 (2013)
Table of Contents
Original Article
| A feasibility study of transurethral resection followed by radiotherapy combined with concurrent twice-weekly gemcitabine in the treatment of invasive bladder carcinoma | |
| Dalia Osama, Mohamed Shalaby, Mohamed Abdelhamed Aboziada | p1 |
| EphA2 protein expression in metastatic renal cell carcinoma treated with VEGF-inhibitors is predictive of patient survival | |
| Christine Eckey, Mathias Gugger, Uyen Huynh-Do | p12 |
| Radiobiological evaluation of dose calculation algorithms in RapidArc planning of esophageal cancer treatment plans | |
| Suresh Rana, Kevin Rogers | p44 |
Case Studies
| Pituitary apoplexy after hypo-fractionated stereotactic radiotherapy | |
| Geetika Bhatt, Aashish D. Bhatt, Craig L. Silverman, Anthony E. Dragun | p22 |
| Gemcitabine, Oxaliplatin and Bevacizumab in patients with biliary tract cancers | |
| Amit Mahipal, Edith Mitchell | p29 |
Case Report
| Prolonged response to trabectedin in a patient with carcinosarcoma of the ovary refractory to adjuvant platinum-taxane | |
| Edgar Petru, Vassiliki Kolovetsiou, Tina Idris | p9 |
| Papillary thyroid cancer with simultaneous iodine-avidity and iodine-resistance in a pregnant patient | |
| Helen Gharwan, Henry G. Fein | p34 |
| A case of chylous mesenteric cyst: unusual presentation | |
| Mohammad Hourani, Mustapha Mneimne, Ashraf Hourani, Nabil Daoud, Nabil Yassin | p39 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Journal of Solid Tumors
ISSN 1925-4067(Print) ISSN 1925-4075(Online)
Copyright © Sciedu Press
To make sure that you can receive messages from us, please add the 'Sciedu.ca' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.